BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35847977)

  • 1. Breast Cancer Subtypes Based on Hypoxia-Related Gene Sets Identify Potential Therapeutic Agents.
    Xiong Z; Huang W; Zhong W; Fu J; Feng J; Wang X; Ling F
    Front Mol Biosci; 2022; 9():900005. PubMed ID: 35847977
    [No Abstract]   [Full Text] [Related]  

  • 2. A Ribosome-Related Prognostic Signature of Breast Cancer Subtypes Based on Changes in Breast Cancer Patients' Immunological Activity.
    Luan T; Song D; Liu J; Wei Y; Feng R; Wang X; Gan L; Wan J; Fang H; Li H; Gong X
    Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984424
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.
    Wu Z; Wan J; Wang J; Meng X; Qian H
    Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
    Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
    Gene; 2022 May; 821():146328. PubMed ID: 35181505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.
    Zhang D; Wang M; Peng L; Yang X; Li K; Yin H; Xia C; Cui F; Huang H; Jin Z
    J Oncol; 2021; 2021():4986227. PubMed ID: 34987579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
    Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
    Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis based on DNA methylation and RNA-seq reveals hypermethylation of the up-regulated WT1 gene with potential mechanisms in PAM50 subtypes of breast cancer.
    Ren C; Tang X; Lan H
    PeerJ; 2021; 9():e11377. PubMed ID: 33987034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
    Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
    Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma.
    Wang F; Tang C; Gao X; Xu J
    Ann Transl Med; 2020 Apr; 8(7):453. PubMed ID: 32395497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity and Extracellular Matrix Characteristics of Breast Cancer Subtypes Based on Identification by T Helper Cells Profiling.
    Zhou Y; Tian Q; Gao H; Zhu L; Zhang Y; Zhang C; Yang J; Wang B
    Front Immunol; 2022; 13():859581. PubMed ID: 35795662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular clustering based on gene set expression and its relationship with prognosis in patients with lung adenocarcinoma.
    Xing B; Shi L; Bao Z; Liang Y; Liu B; Liu R
    J Thorac Dis; 2022 May; 14(5):1638-1650. PubMed ID: 35693605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database.
    Zhang Z; Li Q; Li A; Wang F; Li Z; Meng Y; Zhang Q
    Transl Androl Urol; 2021 Dec; 10(12):4353-4364. PubMed ID: 35070817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma.
    Wu G; Zhu Z; Yang Z; He M; Ren K; Dong Y; Xue Q
    Int J Gen Med; 2022; 15():3991-4006. PubMed ID: 35437352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune Microenvironment.
    Ding R; Liu Q; Yu J; Wang Y; Gao H; Kan H; Yang Y
    ACS Omega; 2023 Apr; 8(13):12217-12231. PubMed ID: 37033796
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Characterization of the Function of Metabolic Genes and Establishment of a Prediction Model in Breast Cancer.
    Yu R; Peng M; Zhao S; Wang Z; Ma Y; Zhang X; Lv X; Wang S; Ju S; Zhao R; Zhou Q; Lian W
    Dis Markers; 2022; 2022():3846010. PubMed ID: 35493305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 12-gene prognostic signature in breast cancer based on the tumor microenvironment.
    Zhu J; Shen Y; Wang L; Qiao J; Zhao Y; Wang Q
    Ann Transl Med; 2022 Feb; 10(3):143. PubMed ID: 35284537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of angiogenesis subtypes for breast cancer: a comprehensive analysis based on the Cancer Genome Atlas.
    Peng XF; Qin FL; Chen WJ; Zhang H; Mai ZY; Zeng J
    J BUON; 2021; 26(5):1975-1990. PubMed ID: 34761608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Distinct Subtypes Revealed in Blood Transcriptome of Breast Cancer Patients With an Unsupervised Analysis.
    Ming W; Xie H; Hu Z; Chen Y; Zhu Y; Bai Y; Liu H; Sun X; Liu Y; Gu W
    Front Oncol; 2019; 9():985. PubMed ID: 31632916
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
    Gan S; Dai H; Li R; Liu W; Ye R; Ha Y; Di X; Hu W; Zhang Z; Sun Y
    Gland Surg; 2020 Jun; 9(3):661-675. PubMed ID: 32775256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.